| 发明名称 |
Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product |
| 摘要 |
Methods are provided for preventing or reducing N-methyl-D-aspartate (NMDA) receptor agonist-mediated neuronal cell death by administering a glial cell line-derived neurotrophic factor (GDNF) protein product. |
| 申请公布号 |
AU2333997(A) |
申请公布日期 |
1997.10.10 |
| 申请号 |
AU19970023339 |
申请日期 |
1997.03.18 |
| 申请人 |
AMGEN INC |
发明人 |
DAVID MARTIN;GERALD D. MILLER |
| 分类号 |
A61K38/22;A61K38/18;A61P25/00;A61P43/00 |
主分类号 |
A61K38/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
